December 11 takes most hemp products off the market. With CareValidate, your brand keeps selling Cannabidiol: pharmaceutical-grade, THC-free, and prescribed.

Move your customers from retail Cannabidiol to prescription cannabidiol. We provide licensed clinicians, LegitScript Certified pharmacies, and prescription-strength dosing. You keep your brand and your customer list.

A licensed clinician decides every prescription · Live within weeks: clinicians and pharmacies already credentialed · Eligibility confirmed by shipping state at intake

✓ Ready-to-run marketing assets, pre-approved by the manufacturer
✓ Made and third-party tested by Kazmira in Colorado
✓ Plugs into your existing storefront
The category, in four facts
0.4 mg

total THC allowed per container after December 11; one dropper of a typical full-spectrum Cannabidiol oil already exceeds it.¹

<0.3 mg

THC was not detected by an independent third-party laboratory in the sample batch tested.⁴

~95%

of hemp-derived cannabinoid products sold today fall outside the new definition (industry estimate).²

0

LegitScript certifications available to ingestible retail Cannabidiol.³

Sources: 1. Federal hemp definition (CRS); Johnson et al., Drug & Alcohol Dependence, 2022 (median 0.64 mg THC/mL in THC-positive Cannabidiol oils) · 2. Wilson Elser, “The Great Hemp Reset,” 2026 · 3. LegitScript Cannabidiol Certification eligibility · 4. Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request; Johnson et al. 2022

The problem

Retail Cannabidiol is about to lose its legal shelf.

On December 11, a new federal rule caps hemp products at 0.4 mg of total THC per container. One dropper of a typical full-spectrum Cannabidiol oil already goes over. Industry estimates put roughly 95% of hemp-derived cannabinoid products sold today outside the new definition.

The damage starts before the deadline. Payment processors and ad platforms are already pulling accounts. Legal counsel is flagging product-liability policies written for a product that’s about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory (Wilson Elser, 2026).

How it works

Plant to prescription, in four steps.

1

Your customer starts with your brand.

You introduce the program through your existing storefront and customer list, with marketing assets supplied by Kazmira.

2

They meet a licensed clinician.

A clinician reviews the patient's intake and medications, asynchronously or by a live visit where state rules require one, and decides whether prescription cannabidiol is appropriate.

3

Their prescription is compounded.

A LegitScript Certified pharmacy compounds the prescribed dose with Kazmira's THC-free cannabidiol and ships it under your brand.

4

Care continues.

Pharmacist check-ins, monthly refills, and dose adjustments when appropriate, all running through your storefront. Same customer relationship, a different level of care.

The Deadline Is the Business Case

Most telehealth categories don't come with a hard deadline. This one does.

“The calls have already started. Operators who built real brands and real customer lists in the hemp space are being told by their payment processors that they have weeks, not years,”

Pulak Sharma, Co-Founder and Co-CEO, Kazmira Therapeutics

Beyond processing, legal counsel is flagging product-liability policies written for a product that's about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory.

Source: Wilson Elser, “The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage”

The demand your customers built isn’t going anywhere; it can no longer be served over the counter. The prescription pathway is regulated under pharmacy law rather than the hemp definition, so neither the November 12 nor the December 11 deadline touches it.

Beyond December 11, a better reason for customers to choose you: most retail Cannabidiol leaves the customer to figure out the product, the dose and the results on their own.

A typical serving holds 5 to 20 mg. Most positive clinical trials used more than 300 mg a day (Chesney et al., 2020), and about 7 in 10 Cannabidiol products sold online are mislabeled (Bonn-Miller et al., JAMA, 2017).

Retail Cannabidiol A prescription turns Cannabidiol into a care plan
low-dose products200 to 400 mg prescribed daily doses
guessing at the dosea licensed clinician reviewing their health and medications
labels that often miss (about 7 in 10 online products)pharmacy-compounded cannabidiol
no medication screeningdrug-interaction screening before every prescription
no clinical follow-uppharmacist and clinician follow-up
no plan when Cannabidiol “doesn’t work”dose adjustment when appropriate, with monthly refills
Plant to prescription: the Cannabidiol your customers came looking for, with a clinician and a pharmacist behind every dose.
Purity block (Cannabidiol in a class of its own)Purity matters when Cannabidiol becomes a prescription. Kazmira’s proprietary purification process was developed over more than a decade to produce cannabidiol at pharmaceutical standards.
Within 3%of label claim in independent testing of the referenced batch.* 29 stepsof proprietary purification, developed by Kazmira’s founders, trained in the oil & gas industry as chemical engineers.† cGMP · ICH Q7 · ISO 9001manufacturing standards for drug ingredients. 3 strengths6,000, 9,000 and 12,000 mg bottles, one for each prescribed daily dose.

* Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request.

† Refining crude oil means separating thousands of similar molecules into pure fractions. Kazmira’s founders learned that work as chemical engineers in oil and gas, then spent more than a decade applying it to the 100+ compounds in cannabis.

Built to connect, not replace

Better for your customers.
Built for your business.

Keep your customers. Your existing customers are the first people you invite. Start before December 11.

Keep your brand. Patients order on your storefront, get support in your name, and receive their prescription under your brand. API-first, so it runs alongside the systems you already have.

Revenue that renews every month. Approved patients refill monthly, as prescribed, through your storefront.

Your patients stay yours. The customer relationship belongs to your storefront. Kazmira fills the prescriptions and doesn’t market to your patients.

Clinicians who know cannabidiol. Training in Kazmira’s clinical protocols (dosing, titration and drug-interaction screening) is available to every prescriber in your network.

A storefront that stands apart. Retail competitors sell another bottle. You offer a prescription program with a clinician and a pharmacist behind it.

Proof Points

First vertically integrated cannabinoid company in the U.S.

API manufacturing, a licensed 503A compounding pharmacy, and a clinician-led telehealth platform, under one roof.

Since 2016

Kazmira, founded in 2016, now runs the nation's first 503A compounding pharmacy dedicated to prescription-only, THC-free Cannabidiol, launched January 2026.

A decade of purification science

Kazmira developed the method to remove every detectable trace of THC from cannabidiol at scale: 29 steps of proprietary purification under cGMP, ICH Q7 and ISO 9001 standards.

Lab-verified

THC was not detected by an independent third-party laboratory in the sample batch tested, and potency within 3% of label claim (Certificate of Analysis, Triverity Laboratories, ISO/IEC 17025, available on request). Three strengths: 6,000, 9,000 and 12,000 mg bottles, one for each prescribed daily dose.

LegitScript Certified Healthcare Merchant

Verifiable at legitscript.com. Ingestible retail Cannabidiol is not eligible for this certification.

Made in Watkins, Colorado

Pharmaceutical-grade API manufactured and third-party tested domestically.

Covered nationally

Quoted in Forbes Health and Denver7; covered by MediaPost, FOX31, the Denver Gazette, Cannabis Business Times and MDLinx; featured in MedCity News.

Clinician education

1Cannabis™, Kazmira’s education platform for clinicians and patients, launched in April 2026 with dosing and drug-interaction protocols built over 18 months.

Features

Document check icon for approvals, completed forms, or validated records.

LegitScript Certified pharmacy fulfillment. Kazmira Pharmacy and its licensed partner hold the state licenses and fill every order, with eligibility confirmed by shipping state at intake.

Flask icon for testing, analysis, or clinical processes.

Licensed clinician network. Credentialed clinicians review each patient and decide whether to prescribe.

Test tubes icon for lab samples, experiments, or clinical testing.

Pharmaceutical-grade, THC-free cannabidiol API. Purified by Kazmira in Watkins, Colorado, and third-party tested.

Truck icon for shipping, logistics, or transportation.

Compounding and shipping. The pharmacy compounds each patient's dose and ships it to their door.

Shield check icon for security, verification, trust, or protection.

Marketing assets supplied by Kazmira. Ads, images and claim language, cleared by Kazmira before they reach you. We recommend that each storefront obtain its own legal review of marketing materials before use.

Chat icon for communication or support.

White-label patient support. Patient questions answered under your brand's name.

Bar chart icon for analytics, reports, metrics, or performance data.

Analytics and performance monitoring. Ongoing monitoring and reporting on your program's performance.

Code brackets icon for development, APIs, integrations, or technical setup.

API-first integration. Connects to the storefront, EHR and fulfillment stack you already run.

FAQ

What exactly is the program?
Is this legal after December 11?
Where can my customers get it?
How fast can I launch?
Do I need my own clinicians or pharmacy relationship?
I already sell hemp-derived Cannabidiol or THC products. Is this for me?
Who owns the patient relationship?
Is this online only?
What does it cost?
Will my customers actually complete a clinician visit?
My customers say Cannabidiol never worked for them. Now what?
What should patients expect in the first few weeks?
Does every customer get a prescription?
What can I say in my marketing, and who approves it?
Is this legitimate?
Do I have to replace my existing systems?

December 11 is coming either way.
Be the brand your customers can still buy from.

Book a demo and we’ll plan your launch before the deadline, whether you’re moving an existing hemp/Cannabidiol brand or launching fresh.

✓ Pharmaceutical-grade cannabidiol
✓ Prescription-strength dosing
✓ Licensed clinical oversight
✓ Pharmacy fulfillment
✓ Ongoing care
✓ Your brand, your customers
Book a Demo
LegitScript Certified
HIPAA
SOC2 Type II

Not all patients are eligible. No guarantee of prescription or outcome. Compounded medications are not FDA-approved. Educational information only; not medical advice.